Skip to main content
Caplight Logo









Duke Street Bio

Duke Street Bio

Private
LondonHealthcare & Life Scienceshttps://dukestbio.com/

Last Round

Seed Round

Jun 11, 2026

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Duke Street Bio is a biotechnology company that develops precision medicine-based cancer therapies targeting DNA damage repair deficiencies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

precision medicineDNA damage repairDDRPARP inhibitoroncology biotechsmall molecule therapyhomologous recombination deficiencyHRDsolid tumor treatmentdrug discoveryclinical stage biotechcancer drug pipelinebiotech startupdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Duke Street Bio Comparables

Compare Duke Street Bio with similar companies based on industry and business-model similarity.

Duke Street Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Synnovation Therapeutics
91%
Tilikum Therapeutics
90%
Idience Co., Ltd.
86%

Duke Street Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 11, 2026
Seed RoundJan 17, 2024
VC RoundMay 22, 2022

Key People

Founding team and executive leadership

Barry McGuinness

Chief Operating Officer and Co-Founder

Founding Team

Phill Cowley

Chief Scientific Officer and Co-Founder

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 40% MoM, reaching 1.3K.

  • Jun 11, 2026

    Raised $4.1M in a seed funding round.

Duke Street Bio Filings

Explore SEC and related filing metadata, where available.

Duke Street Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Duke Street Bio's valuation, stock price, and market status.

Is Duke Street Bio a public or private company?

Duke Street Bio is a private company.

What is the current stock price of Duke Street Bio?

Duke Street Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Duke Street Bio worth (valuation)?

Valuation information for Duke Street Bio is not publicly available.

Can I buy Duke Street Bio stock?

Duke Street Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Duke Street Bio's last funding round?

Duke Street Bio's most recent funding round was Seed Round on June 11, 2026.

Who are the main investors in Duke Street Bio?

Investor information for Duke Street Bio is not publicly disclosed.

Will Duke Street Bio IPO soon?

No public IPO plans have been announced for Duke Street Bio.

How can I track Duke Street Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Duke Street Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range8
Year Founded2020
Last FundingJun 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?